Clinical trial demonstrates safety of targeted treatment approach for deadly brain tumor in children

Clinical trial demonstrates safety of targeted treatment approach for deadly brain tumor in children

A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic pontine glioma (DIPG) is safe, reported Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center investigators.

Disulfiram-loaded electrospun fibers with antimicrobial and antitumoral properties for glioblastoma treatment

Glioblastoma (GB) is a malignant brain tumor with low survival rates and a high recurrence ratio due to limited therapeutic arsenal. The repurposed dr…

Scientists from the Institute of Biology and Biomedicine of the National Research University of Nizhny Novgorod and Ghent University (Belgium) have discovered a new method for treating the most aggressive brain tumor – glioblastoma. The new method is based on the simultaneous activation of several killer cell cascades to combat different malignant tumor cells. This technique could reduce tumor resistance to temozolomide. The researchers have alr…

FDA Approves Initiation of a New Trial in Recurrent Glioblastoma

The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a form of brain cancer.